UK agency says Pfizer breast cancer drug too expensive supriya kashyap kashyap6 Feb 2017 10:41 AM ISTPfizer's breast cancer drug Ibrance, or palbociclib, is too expensive to justify its use on Britain's state-run health service, the country's...
Glenmark Pharma climbs nearly 7 percent on smart Q3 earnings supriya kashyap kashyap6 Feb 2017 10:40 AM ISTNew Delhi : Shares of Glenmark Pharmaceuticals jumped nearly 7 per cent after the company reported an over two-fold jump in consolidated net profit...
Portuguese regulator completes Granules plant re-inspection supriya kashyap kashyap5 Feb 2017 12:15 PM ISTNew Delhi : Drug firm Granules India said re-inspection of its manufacturing facility at Gagillapur in Telangana has been successfully completed by...
Merck 2017 forecast reassuring; full-speed ahead with Keytruda supriya kashyap kashyap5 Feb 2017 12:15 PM ISTMerck & Co Inc (MRK.N), faced with patent expiration's and increasing development costs for its high-profile Keytruda cancer immunotherapy,...
Amgen cholesterol drug succeeds in cutting serious heart problems: Study supriya kashyap kashyap5 Feb 2017 12:05 PM ISTAmgen Inc said its potent cholesterol fighter Repatha significantly reduced the risk of heart attacks, strokes and death in patients with heart...
Lupin gets final USFDA nod for Mylan's skin disease cream supriya kashyap kashyap4 Feb 2017 12:10 PM ISTNew Delhi : Pharma major Lupin said it has received final approval from the US health regulator to market its generic version of Mylan's triamcinolone...
AstraZeneca Pharma Q3 net up 84 pc to Rs 16 crore supriya kashyap kashyap4 Feb 2017 12:10 PM ISTDelhi : Drug firm AstraZeneca Pharma reported an 84.08 per cent increase in its standalone net profit at Rs 15.96 crore for the third quarter ended...
USFDA approves Bristol-Myers Opdivo for bladder cancer supriya kashyap kashyap4 Feb 2017 12:06 PM ISTThe U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co's Opdivo to include treatment of urothelial carcinoma, the most...
Dishman Pharma receives EIR report from USFDA supriya kashyap kashyap3 Feb 2017 12:27 PM ISTNew Delhi : Drug firm Dishman Pharmaceuticals and Chemicals Ltd has received Establishment Inspection Report (EIR) from the US health regulator on...
Strides Shasun receives USFDA tentative nod for Fingolimod capsules supriya kashyap kashyap3 Feb 2017 12:27 PM ISTMumbai : Pharma firm Strides Shasun Limited announced that its subsidiary Strides Pharma Global Pte Limited, Singapore has received tentative approval...
Reckitt Benckiser in talks to buy Mead Johnson for $16.7 billion supriya kashyap kashyap3 Feb 2017 12:27 PM ISTUK consumer goods maker Reckitt Benckiser Group Plc said it was in advanced talks to buy baby formula maker Mead Johnson Nutrition Co in a $16.7...
Sanofi's Xyzal Allergy 24HR Approved for OTC Use in the United States supriya kashyap kashyap3 Feb 2017 12:26 PM ISTBridgewater : Sanofi announced that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-counter (OTC) treatment...
